嘎日迪散治疗溃疡性结肠炎60例临床观察  

Clinical observation on Garidisan in 60 patients with ulcerative colitis

作　　者：崔箭[1] 庞宗然[1] 德利格玛[2] 鲁碧楠[1] 刘伟志[1] 

机构地区：[1]中央民族大学中国少数民族传统医学研究院,北京100081 [2]内蒙古医学院,呼和浩特010050

出　　处：《天津中医药》2012年第1期17-18,共2页Tianjin Journal of Traditional Chinese Medicine

基　　金：中国少数民族传统医学教育部创新团队资助项目(IRT0871)

摘　　要：[目的]观察口服嘎日迪散治疗慢性溃疡性结肠炎的疗效。[方法]将120例溃疡性结肠炎患者按随机数字表法分为治疗组60例,采用口服嘎日迪散治疗;对照60例,采用口服柳氮磺嘧啶(SASP)治疗。[结果]治疗组总有效率为93.3%,对照组总有率为73.3%,两组比较具有统计学差异(P<0.05);两组治疗前后腹痛、腹泻、黏液脓血便、里急后重主要临床症状同组比较差异有统计学意义(P<0.05)。[结论]嘎日迪散治疗溃疡性结肠炎疗效显著,且无不良反应。[Objective] To observe the clinical effect of Garidisan in treating ulcerative colitis. [Methods] One hundred and twenty pa- tients were randomly divided into two groups. Sixty patients in treatment group were treated with Garidisan, while 60 patients in control group received oral Salazosulfadimidine （SASP）. [Results] The effective rate of treatment group was 93.3% and control group was 73.3%. There were significant differences between two groups （P〈0.05）. After treatment of Garidisan, the main symptoms of ulcerative colitis, such as diarrhea, abdominal pain, mucous stool with pus and blood and tenesmus, were significantly improved. [Conclusion] Garidisan has a significant clinical effect in treating ulcerative colitis and its signs without any adverse reaction.

关 键 词：溃疡性结肠炎 蒙医药疗法 嘎日迪散 

分 类 号：R574.62[医药卫生—消化系统]